BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1520 related articles for article (PubMed ID: 3158707)

  • 1. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.
    Susskind BM; Chandrasekaran J
    J Immunol; 1987 Aug; 139(3):905-12. PubMed ID: 2955052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them.
    Fink PJ; Rammensee HG; Bevan MJ
    J Immunol; 1984 Oct; 133(4):1775-81. PubMed ID: 6332132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of T cell-mediated cytolysis by monoclonal antibodies directed against Lyt-2: heterogeneity of inhibition at the clonal level.
    MacDonald HR; Thiernesse N; Cerottini JC
    J Immunol; 1981 May; 126(5):1671-5. PubMed ID: 6452474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies.
    Malissen B; Rebai N; Liabeuf A; Mawas C
    Eur J Immunol; 1982 Sep; 12(9):739-47. PubMed ID: 6982820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal anti-Lyt-2 antibodies block the activation of cytolytic T lymphocyte precursors.
    Glasebrook AL; MacDonald HR
    J Immunol; 1983 Apr; 130(4):1552-5. PubMed ID: 6220055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulation by mouse T cell clones. III. Cloned H-Y-specific cytotoxic T cells secrete a soluble mediator(s) that inhibits cytotoxic responses by acting on both Lyt-2- and L3T4- lymphocytes.
    Simon MM; Nerz G; Prester M; Moll H
    Eur J Immunol; 1985 Aug; 15(8):773-83. PubMed ID: 2411568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
    Havran WL; Fitch FW
    J Immunol; 1988 Sep; 141(6):1808-12. PubMed ID: 2459190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemic cells arise from cloned cytotoxic lymphocytes during cell culture.
    Simon MM; Ali S; Tewari R; Simon HG; Müller-Hermelink HK; Epplen JT
    Eur J Immunol; 1986 Oct; 16(10):1269-76. PubMed ID: 3095125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of specificity in cytolytic T lymphocyte clones: two broad specificity, H-2-independent recognition systems, one natural killer-like, develop during culture, in addition to the clonally distributed antigen-specific receptor.
    Wilson A; Shortman K
    Eur J Immunol; 1985 Sep; 15(9):899-905. PubMed ID: 2412835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.
    Fink PJ; Rammensee HG; Benedetto JD; Staerz UD; Lefrancois L; Bevan MJ
    J Immunol; 1984 Oct; 133(4):1769-74. PubMed ID: 6236258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hapten-specific cytotoxic T cell clones undergo somatic variation of their antigen recognition specificity.
    Weltzien HU; Kempkes B; Jankovic DL; Eichmann K
    Eur J Immunol; 1986 Jun; 16(6):631-9. PubMed ID: 2424767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination.
    Kuribayashi K; Tanaka C; Matsubayashi Y; Masuda T; Udono H; Abe M; Nakayama E; Shiku H
    J Immunol; 1988 Dec; 141(11):4074-80. PubMed ID: 2460558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.